Related Experiment Video
Updated: Apr 20, 2026

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions
Published on: April 21, 2016
Paradoxical inhibition of cellular protein expression by proteasome inhibitors
Abstract:
Abstract Proteasome inhibitors are used as anticancer drugs, however, the precise mechanisms of their selective activity against cancer cells are not understood well. While proteasome inhibitors stabilize the majority of cellular proteins through inhibition of proteasome activity, they also paradoxically downregulate several other proteins. We recently discovered that proteasome inhibitors suppress mRNA and protein expression of FOXM1, NPM, and ARF proteins that are involved in cancer. We postulated that proteasome inhibitors preferentially stabilize negative regulators of transcription of these genes, which overrides their protein stabilization. These data suggest a presence of multiple secondary mechanisms that may regulate transcription, degradation, or localization of cellular proteins after treatment with proteasome inhibitors. Future experiments will identify these mechanisms and additional proteins suppressed by proteasome inhibitors, and will help explain the role of protein suppression by proteasome inhibitors in their anticancer activity.
Insights
Proteasome inhibitors, used in cancer therapy, paradoxically downregulate key cancer proteins like FOXM1. This study reveals secondary mechanisms, not just protein stabilization, contribute to their anticancer effects.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Proteasome inhibitors are established anticancer agents.
- Their precise mechanisms for selective cancer cell targeting remain incompletely understood.
- While inhibiting proteasome activity stabilizes most proteins, some are paradoxically downregulated.
Purpose of the Study:
- To investigate the mechanisms behind the paradoxical downregulation of specific proteins by proteasome inhibitors.
- To identify key cancer-related proteins affected by proteasome inhibitors.
- To elucidate the role of these downregulation mechanisms in the overall anticancer activity.
Main Methods:
- Analysis of proteasome inhibitor effects on mRNA and protein expression.
- Focus on transcription factors and regulators involved in cancer pathways.
- Postulation of secondary mechanisms overriding direct protein stabilization.
Main Results:
- Proteasome inhibitors were found to suppress mRNA and protein expression of FOXM1, NPM, and ARF.
- These proteins are critically involved in cancer development and progression.
- A hypothesis was proposed: preferential stabilization of negative transcriptional regulators overrides general protein stabilization.
Conclusions:
- Proteasome inhibitors employ multiple, secondary mechanisms beyond direct protein stabilization.
- These mechanisms involve regulation of transcription, degradation, or localization of cellular proteins.
- Further research is needed to identify all suppressed proteins and fully understand their role in proteasome inhibitor anticancer efficacy.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial Protein Synthesis
Regulation of Expression at Multiple Steps

